Topics

Renuvion Dermal System for Dermal Resurfacing

2019-12-10 01:21:01 | BioPortfolio

Summary

This is a multi-center, single arm, evaluator-blind prospective study of up to 55 study subjects who are seeking a procedure to reduce the appearance of wrinkles and rhytides.

Description

This is a multi-center, single arm, evaluator-blind prospective study of up to 55 study subjects who are seeking a procedure to reduce the appearance of wrinkles and rhytides. All study subjects will be treated with the Renuvion Dermal System.

The study population will consist of males and females, 30 years of age or older, requesting a procedure for the purpose of improving facial appearance by reducing facial wrinkles and rhytides. Those subjects who meet eligibility criteria and agree to provide written informed consent will be invited to participate.

Study Design

Conditions

Wrinkle

Intervention

Renuvion Dermal System

Location

Michael Lin, MD
Sherman Oaks
California
United States
91403

Status

Recruiting

Source

Apyx Medical

Results (where available)

View Results

Links

Published on BioPortfolio: 2019-12-10T01:21:01-0500

Clinical Trials [247 Associated Clinical Trials listed on BioPortfolio]

Inter-observer and Intra-observer Variability of the Wrinkle Test

Skin wrinkling of the fingers following immersion in warm water depends on intact sympathetic innervation. It is abolished by lesions affecting both central and peripheral sympathetic path...

Pivotal Study of the Cutera truSculpt Radiofrequency Device for Wrinkle Reduction

The purpose of this pivotal investigation is to evaluate the safety and efficacy of the Cutera truSculpt™ radiofrequency (RF) Device for Wrinkle Reduction.

Novel Compositions for Treating or Preventing Dermal Disorders

This trial examines the impact of a topical formulation of rapamycin on dermal thickness and senescence.

Histological and Microbiological Evaluation of Late Occurring Nodules With Hyaluronic Acid Dermal Fillers

This study will determine if HA dermal filler late occurring (> 4 weeks and

Acellular Dermal Matrix in Breast Reconstruction

Allogenic acellular dermal matrix has been used in burn injuries or abdominal walls reconstructions. However, it is solely used in breast reconstructions after breast carcinoma amputation....

PubMed Articles [8553 Associated PubMed Articles listed on BioPortfolio]

Anti-skin aging properties of protocatechuic acid in vitro and in vivo.

Protocatechuic acid has reported containing antioxidant effects. However, information on its other biological activities such as anti-wrinkle properties is limited AIMS: The objective of this study wa...

A 3D construct of the intestine canal with wrinkle morphology on a centrifugation configuring microfluidic chip.

A new in vitro gut microfluidic chip that mimics the in vivo intestine canal morphology and stimulation is developed to contribute to tissue engineering, intestine development and function research. T...

Utilizing human dermal fibroblast heterogeneity in autologous dermal fibroblast therapy: an overcomplicated strategy or a promising approach?

Although human dermal fibroblast heterogeneity has been acknowledged for several decades; and a large body of in vitro studies have been performed with zonal dermal fibroblast, current autologous derm...

Differential Roles of the mTOR-STAT3 Signaling in Dermal γδ T Cell Effector Function in Skin Inflammation.

Dermal γδT cells play critical roles in skin homeostasis and inflammation. However, the underlying molecular mechanisms by which these cells are activated have not been fully understood. Here, we sh...

Low molecular polypeptide from oyster hydrolysate recovers photoaging in SKH-1 hairless mice.

When the human skin is chronically exposed to external stimuli such as ultraviolet (UV) radiation, the skin tissue suffers damage and the structure of the extracellular matrix (ECM) in the skin is dis...

Medical and Biotech [MESH] Definitions

Synthetic material used for the treatment of burns and other conditions involving large-scale loss of skin. It often consists of an outer (epidermal) layer of silicone and an inner (dermal) layer of collagen and chondroitin 6-sulfate. The dermal layer elicits new growth and vascular invasion and the outer layer is later removed and replaced by a graft.

Mucoid states characterized by the elevated deposition and accumulation of mucin (mucopolysaccharides) in dermal tissue. The fibroblasts are responsible for the production of acid mucopolysaccharides (GLYCOSAMINOGLYCANS) in the ground substance of the connective tissue system. When fibroblasts produce abnormally large quantities of mucopolysaccharides as hyaluronic acid, chondroitin sulfate, or heparin, they accumulate in large amounts in the dermis.

Materials such as COLLAGEN or HYALURONIC ACID that are injected or deposited into the DERMIS for the purpose of skin augmentation.

A group of enzymatic disorders affecting the nervous system and to a variable degree the skeletal system, lymphoreticular system, and other organs. The conditions are marked by an abnormal accumulation of catabolic material within lysosomes.

The system of glands that release their secretions (hormones) directly into the circulatory system. In addition to the ENDOCRINE GLANDS, included are the CHROMAFFIN SYSTEM and the NEUROSECRETORY SYSTEMS.

More From BioPortfolio on "Renuvion Dermal System for Dermal Resurfacing"

Quick Search

Searches Linking to this Trial